Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein.
Pharmacol Res. 2022 Jan;175:105975. doi: 10.1016/j.phrs.2021.105975. Epub 2021 Nov 14.
Pharmacol Res. 2022.
PMID: 34785319
Free article.
Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975].
Abd-Ellatef GEF, Gazzano E, El-Desoky AH, Hamed AR, Kopecka J, Belisario DC, Costamagna C, Marie MAS, Fahmy SR, Abdel-Hamid AZ, Riganti C.
Abd-Ellatef GEF, et al.
Pharmacol Res. 2023 Mar;189:106708. doi: 10.1016/j.phrs.2023.106708. Epub 2023 Mar 2.
Pharmacol Res. 2023.
PMID: 36868967
Free article.
No abstract available.
Item in Clipboard
Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells.
Fathy Abd-Ellatef GE, Gazzano E, Chirio D, Hamed AR, Belisario DC, Zuddas C, Peira E, Rolando B, Kopecka J, Assem Said Marie M, Sapino S, Ramadan Fahmy S, Gallarate M, Abdel-Hamid AZ, Riganti C.
Fathy Abd-Ellatef GE, et al.
Pharmaceutics. 2020 Jan 24;12(2):96. doi: 10.3390/pharmaceutics12020096.
Pharmaceutics. 2020.
PMID: 31991669
Free PMC article.
Item in Clipboard
Cite
Cite